The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

19 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere.EBI
Vanderbilt University School of Medicine
Synthesis and evaluation of¿-lactam analogs of PGE2 as EP4 and EP2/EP4 agonists.EBI
Minase Research Institute
Discovery of new chemical leads for prostaglandin D2 receptor antagonists.EBI
Minase Research Institute
Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists.EBI
Minase Research Institute
Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity.EBI
Minase Research Institute
Synthesis and evaluation of novel modified¿-lactam prostanoids as EP4 subtype-selective agonists.EBI
Minase Research Institute
Design and synthesis of new prostaglandin D2 receptor antagonists.EBI
Minase Research Institute
Discovery of selective indole-based prostaglandin D2 receptor antagonist.EBI
Minase Research Institute
3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 3: Synthesis, metabolic stability, and biological evaluation of optically active analogs.EBI
Minase Research Institute
Discovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists.EBI
Minase Research Institute
3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 1: discovery and exploration of the carboxyamide side chain.EBI
Minase Research Institute
3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. part 2: optimization of the side chains to improve in vitro and in vivo potencies.EBI
Minase Research Institute
Discovery of orally active prostaglandin D2 receptor antagonists.EBI
Minase Research Institute
Design and synthesis of a highly selective EP4-receptor agonist. Part 2: 5-thia and 9beta-haloPG derivatives with improved stability.EBI
Minase Research Institute
Design and synthesis of a highly selective EP4-receptor agonist. Part 1: 3,7-dithiaPG derivatives with high selectivity.EBI
Minase Research Institute
Design and synthesis of a highly selective EP2-receptor agonist.EBI
Minase Research Institute
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.BDB
Case Western Reserve University